Is a controlled trial of long-term oral anticoagulants in patients with stroke and non-rheumatic atrial fibrillation worthwhile?
A controlled randomised trial large enough to assess the value of anticoagulating stroke patients in atrial fibrillation would be difficult to conduct in the UK and the results would be applicable to only a small proportion of stroke patients. It would be more worthwhile to organise a trial that als...
Հիմնական հեղինակներ: | Sandercock, P, Warlow, C, Bamford, J, Peto, R, Starkey, I |
---|---|
Ձևաչափ: | Journal article |
Լեզու: | English |
Հրապարակվել է: |
1986
|
Նմանատիպ նյութեր
-
A new era of anticoagulant therapy in the prevention of stroke in non-rheumatic atrial fibrillation
: Andrei Viktorovich Fonyakin, և այլն
Հրապարակվել է: (2012-09-01) -
Adherence to oral anticoagulation in ischemic stroke patients with atrial fibrillation
: Paula Tiili, և այլն
Հրապարակվել է: (2021-01-01) -
Old and new oral anticoagulants for secondary stroke prevention in atrial fibrillation
: Tommaso Sacquegna, և այլն
Հրապարակվել է: (2015-12-01) -
Prevalence of oral anticoagulation in atrial fibrillation
: Eduardo Bartholomay, և այլն
Հրապարակվել է: (2014-09-01) -
Oral anticoagulant decreases stroke recurrence in patients with atrial fibrillation detected after stroke
: Jin-Yi Hsu, և այլն
Հրապարակվել է: (2022-07-01)